-
-
-
-
-
-
-
Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial
-
-
-
-
-
-
-
BTIG Downgrades Outlook Therapeutics Incs. (OTLK) to Neutral
-
-
-
-
-
10,210 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

